Abstract

Recruitment of mesenchymal stem cells (MSC) following cardiac injury, such as myocardial infarction, plays a critical role in tissue repair and may contribute to myocardial recovery. However, the mechanisms that regulate migration of MSC to the site of tissue damage remain elusive. Here, we demonstrate in vitro that activated platelets substantially inhibit recruitment of MSC toward apoptotic cardiac myocytes and fibroblasts. The alarmin high mobility group box 1 (HMGB1) was released by platelets upon activation and mediated inhibition of the cell death-dependent migratory response through Toll-like receptor (TLR)-4 expressed on the MSC. Migration of MSC to apoptotic cardiac myocytes and fibroblasts was driven by hepatocyte growth factor (HGF), and platelet activation was followed by HMGB1/TLR-4-dependent down-regulation of HGF receptor MET on MSC, thereby impairing HGF-driven MSC recruitment. We identify a novel mechanism by which platelets, upon activation, interfere with MSC recruitment to apoptotic cardiac cells, a process that may be of particular relevance for myocardial repair and regeneration.

Highlights

  • Mesenchymal stem cells (MSC) contribute to cardiac repair after myocardial injury

  • Migration of MSC to apoptotic cardiac myocytes and fibroblasts was driven by hepatocyte growth factor (HGF), and platelet activation was followed by high mobility group box 1 (HMGB1)/ Toll-like receptor (TLR)-4-dependent down-regulation of HGF receptor MET on MSC, thereby impairing HGF-driven MSC recruitment

  • Activated Platelets Inhibit Migration of MSC to Apoptotic Cardiac Myocytes and Fibroblasts—To investigate whether platelets have an influence on recruitment of MSC to apoptotic cardiac myocytes and fibroblasts, MSC were preincubated with conditioned medium (CM) derived from activated (CRP- or ADP-treated) or non-ac

Read more

Summary

Background

Mesenchymal stem cells (MSC) contribute to cardiac repair after myocardial injury. Underlying molecular mechanisms remain unexplored. Results: Activated platelets inhibit recruitment of MSC to apoptotic cardiac myocytes and fibroblasts via HMGB1/TLR-4mediated down-regulation of HGF receptor MET. Migration of MSC to apoptotic cardiac myocytes and fibroblasts was driven by hepatocyte growth factor (HGF), and platelet activation was followed by HMGB1/ TLR-4-dependent down-regulation of HGF receptor MET on MSC, thereby impairing HGF-driven MSC recruitment. Mesenchymal stem cells (MSC), multipotent non-hematopoietic stem cells that typically originate from the bone marrow (4 –5), have been suggested to play a critical role in repair and regeneration of the injured myocardium [6, 7] Besides their capability of differentiating into cardiac myocytes [8] and fibroblasts [9], which are the main cellular constituents of the heart, they exert antiapoptotic and antifibrotic effects that may prevent cardiac remodeling [10, 11]. We provide evidence for the first time that platelet activation impairs MSC migration to apoptotic cardiac cells and identify the molecular mechanism that mediates this platelet/MSC interaction

EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call